Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.
|Title||Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.|
|Publication Type||Journal Article|
|Year of Publication||2019|
|Authors||Daneault J-G, Maraj A, Lepage M, Malla A, Schmitz N, Iyer SN, Joober R, Shah JL|
|Journal||Acta Psychiatr Scand|
|Date Published||2019 04|
OBJECTIVE: The experience of pre-onset subthreshold psychotic symptoms (STPS, signifying a clinical high-risk state) in first episode psychosis (FEP) predicts poorer outcomes during treatment, possibly through differential adherence to medication. We explored whether adherence differs between FEP patients with and without pre-onset STPS.METHODS: Antipsychotic medication adherence was compared in 263 STPS+ and 158 STPS- subjects in a specialized early intervention program for FEP. Data were gathered from a larger observational study conducted between 2003 and 2016. STPS status, sociodemographic, and baseline clinical variables were tested as predictors of non-adherence using univariate and multivariate logistic regressions. Time to onset of non-adherence was analyzed using Kaplan-Meier curves. The same predictors were tested as predictors of time to onset of non-adherence using Cox regression models.RESULTS: Medication non-adherence was higher in STPS+ participants (78.9% vs. 68.9%). STPS status (OR 1.709), substance use disorder (OR 1.767), and milder positive symptoms (OR 0.972) were significant baseline predictors of non-adherence. Substance use disorder (HR 1.410), milder positive symptoms (HR 0.990), and lack of contact between the clinical team and relatives (HR 1.356) were significant baseline predictors of time to non-adherence.CONCLUSION: FEP patients who experience pre-onset STPS are more likely to be non-adherent to antipsychotic medication over 2 years of intervention. FEP programs should routinely evaluate pre-onset symptomatology to deliver more personalized treatments, with emphasis on engaging both patients and family members from the beginning of care.
|Alternate Journal||Acta Psychiatr Scand|
|PubMed Central ID||PMC6426680|
|Grant List|| / / Canada Research Chairs Program / International |
/ / Canadian Institute of Health Research / International
/ / James McGill Professorship / International
/ / Fonds de Recherche du Québec - Santé / International
R01 MH093303 / MH / NIMH NIH HHS / United States
MH093303 / MH / NIMH NIH HHS / United States